Stock Ratings / Health Care / PLSM / forecast

FEMY (35) ICU (33) AEMD (44) NMTC (49) ⌘ Pro Terminal →

Pulsenmore Ltd. (PLSM) 12-Month Stock Forecast & Price Target Cone

Q: What is PLSM's 12-month stock price target?

Pulsenmore Ltd. (PLSM) carries a 12-month consensus base price target of $1.55 (-4.3% from $1.62), with a bull-case target of $13.62 and a bear-case floor of $1.21.

Q: Is PLSM stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates PLSM D (Sell — SELL) with an RQD Confidence score of 48/100.

$1.62 -8.48% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.59

Pulsenmore Ltd. (PLSM) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D • SELL / AVOID Cap $10.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.59 (-1.72%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.6% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-4.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PLSM)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (48/100 Composite)

🔍 WHY PLSM SCORES 48/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (27% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (25% of score)

SEC XBRL Trailing 12 Months: 0% FCF Margin ($295.0K FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$1.85+1.1% Next Q

Q2 (-2Q)

Grade C-$1.87-5.3% Next Q

Q3 (-1Q)

Grade C-$1.77-8.5% Next Q

Current

Grade D$1.62-5.6% Hist 90D α

Trajectory: C (56) → D (48)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a PLSM Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While PLSM currently carries a cautious 48/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.22) and Max Pain ($1.70) forces dealer call-delta covering toward $13.62.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $PLSM• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “PLSM Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 48%NO 52%Trade / Inspect Odds →

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your PLSM Position Size: $10,000

Shares at $1.62: 6172.8 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $1.21

$7,469

$-2,531 (-25.3%)

12M Consensus BaseTarget $1.55

$9,568

$-432 (-4.3%)

12M Bull Case BreakoutTarget $13.62

$84,074

+$74,074 (+740.7%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (32 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 6

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$2	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$13	69%	B
JP MorganUS Large-Cap Research	SELL	$1	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PLSM)

✓Walkthrough of PLSM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

PLSM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -52.21%⚡ TESTING RESISTANCE

2026-10-30O $1.80H $1.80L $1.57C $1.62VOL 11.3K

RES: $1.77SUP: $1.45SMA50: $2.22SMA200: $3.73

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PLSM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PLSM Butterfly Map → + Track PLSM →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PLSM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PLSM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PLSM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PLSM)

Health Care Rank #395 of 1016 ⚔️ FEMY vs PLSM Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PLSM vs. FEMY, ICU, AEMD, NMTC)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Pulsenmore Ltd. (PLSM) ranks #395 by composite RQD confidence (48/100, grade D) and #894 by equity capitalization ($10.5M). Within this direct 5-issuer industry benchmark cohort, PLSM leads on earnings valuation at N/A trailing P/E, while FEMY leads on capital efficiency and profitability with -35.0% ROIC and 62.0% gross margin. NMTC currently holds the highest overall quantitative score in the immediate peer group at 49/100 (D) compared with PLSM at 48/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
PLSM ACTIVE Pulsenmore Ltd.	D	48/100	—	—	—	-8.48%	$10.5M	Benchmark Subject
FEMY Femasys Inc.	D-	35/100	—	62.0%	-35.0%	-3.90%	$11.3M	/femy-vs-plsm →
ICU SeaStar Medical Holding Corporation	E	33/100	—	95.7%	-35.0%	-6.85%	$12.2M	/icu-vs-plsm →
AEMD Aethlon Medical Inc.	D	44/100	—	—	-35.0%	-0.54%	$8.9M	/aemd-vs-plsm →
NMTC NeuroOne Medical Technologies Corporation	D	49/100	—	56.5%	-35.0%	+12.96%	$8.8M	/nmtc-vs-plsm →

2. PLSM Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

Pulsenmore Ltd. (PLSM) operates in Medical/Dental Instruments (Health Care) with an equity capitalization of $10.5M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. PLSM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PLSM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Pulsenmore Ltd. (NASDAQ: PLSM) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $1.62 (-8.48% 1D, market cap $10.5M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, PLSM ranks #395 in composite RQD confidence.

How does PLSM compare to FEMY and ICU in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), PLSM carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, FEMY (Femasys Inc.) holds a D- grade (35/100 RQD, P/E N/A, ROIC -35.0%, cap $11.3M) and ICU (SeaStar Medical Holding Corporation) posts a E grade (33/100 RQD, P/E N/A, ROIC -35.0%, cap $12.2M). Among the 5-stock peer group, PLSM leads on earnings multiple (N/A) while FEMY leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PLSM?

For Pulsenmore Ltd. (PLSM), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #395 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PLSM trading relative to its 50-day, 200-day, and 52-week technical levels?

PLSM last traded at $1.62 (-8.48% on volume of 8,675 shares), positioning the stock -27.03% below its 50-day simple moving average ($2.22) and -56.57% below its 200-day simple moving average ($3.73). Across its 52-week range of $1.57 to $12.97, PLSM sits at the 0.4% percentile with a 14-day RSI of 31.9 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.42 to $1.82).

PLSM Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is PLSM's 12-month stock price target?

Pulsenmore Ltd. (PLSM) carries a 12-month consensus base price target of $1.55 (-4.3% from $1.62), with a bull-case target of $13.62 and a bear-case floor of $1.21.

Is PLSM stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates PLSM D (Sell — SELL) with an RQD Confidence score of 48/100.

Direct Sub-Reports: PLSM RQD Cockpit PLSM 12M Forecast PLSM Earnings & Move PLSM Dividends & DRIP PLSM Insiders & 13F PLSM Whale Options PLSM Profit Sankey PLSM News & Why